PLK4 and breast carcinoma: PLK4 is often aberrantly expressed in breast cancer, which can lead to abnormal centrosome duplication and aneuploidy, thereby inducing genomic instability and consequently contributing to breast cancer tumorigenesis and poor clinical prognosis (30).